Calithera Biosciences Company Top Management

Calithera Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.5629) % which means that it has lost $0.5629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1414) %, meaning that it created substantial loss on money invested by shareholders. Calithera Biosciences' management efficiency ratios could be used to measure how well Calithera Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Almost 72.17 percent of Calithera Biosciences outstanding shares are held by general public with 1.07 (percent) owned by insiders and only 26.76 % by other corporate entities. Some institutional investors establish a significant position in pink sheets such as Calithera Biosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Calithera Biosciences, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Calithera Biosciences Workforce Comparison

Calithera Biosciences Benchmark Summation

Calithera Biosciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Calithera Biosciences often depends on how effective the management is. Calithera Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Calithera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Calithera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Calithera Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Calithera Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Calithera Biosciences' management manipulating its earnings.

When running Calithera Biosciences' price analysis, check to measure Calithera Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calithera Biosciences is operating at the current time. Most of Calithera Biosciences' value examination focuses on studying past and present price action to predict the probability of Calithera Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calithera Biosciences' price. Additionally, you may evaluate how the addition of Calithera Biosciences to your portfolios can decrease your overall portfolio volatility.